ABAjibola B. Bakare

Ajibola B. Bakare

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ajibola B. Bakare has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cochlear Implantation in Sickle Cell Disease: A Systematic Review of Feasibility and Outcomes

    by Jasmine Stewart, Kenny Nguyen, Ajibola B. Bakare, Lindsay Blake, Robert Saadi

    Introduction: Sickle cell disease (SCD) is associated with systemic complications, including sensorineural hearing loss (SNHL) from microvascular occlusion and chronic inflammation. Although reports link SCD to higher rates of SNHL, current evidence is limited by small sample size, varied audiologic methods, and lack of standardized screening. This systematic review summarizes available literature on SNHL and cochlear implantation (CI) in SCD. Methods: A literature search of PubMed MEDLINE, Embase, Scopus, Web of Science, and CINAHL identified 79 citations. After removal of duplicates, 35 records were screened in Rayyan. Studies published between January 1, 2000, and June 30, 2025, were eligible if they reported patients with SCD who developed hearing loss and underwent CI. Nine full texts were reviewed, and 4 met the inclusion criteria. Screening and review were performed independently by 2 authors per PRISMA guidelines. Results: Across 4 case reports, a total of 5 patients with SCD underwent CI, ranging in age from 2 to 42 years. Four presented with bilateral severe-to-profound SNHL and one with unilateral loss. Implantation was technically feasible in all cases, including patients with cochlear fibrosis or ossification requiring modified insertion techniques. Postoperative outcomes were favorable: all patients demonstrated reliable device function and low impedances. Only 60% showed meaningful auditory benefit, characterized by improved functional speech perception in 2 patients (40%) and access to the speech frequency range with hearing testing going from moderate/profound hearing loss to mild hearing loss in 3 patients (60%). Complications occurred in 2 patients (40%): one developed unilateral middle ear infection leading to meningitis, and another experienced a postoperative pulmonary embolism requiring anticoagulation. The remaining 3 patients (60%) had uncomplicated recoveries with reported improved hearing from moderate/profound hearing loss to mild hearing loss post implantation. Conclusion: While CI appears feasible in SCD, our findings suggest that additional data are needed to assess its effectiveness in this patient population. However, evidence is limited to case reports, and complications such as thromboembolism and rapid cochlear fibrosis highlight the need for close perioperative management. More comprehensive studies with larger sample size are required to define surgical risk, optimize management, and establish best practices for timely implantation in this population.

  • Open Access

    Assessing Large Language Models for Early Article Identification in Otolaryngology—Head and Neck Surgery Systematic Reviews

    by Ajibola B. Bakare, Young Lee, Jhuree Hong, Claus‐Peter Richter, Jonathan P. Kuriakose

    Background: Assess ChatGPT and Bard's effectiveness in the initial identification of articles for Otolaryngology—Head and Neck Surgery systematic literature reviews. Methods: Three PRISMA‐based systematic reviews (Jabbour et al. 2017, Wong et al. 2018, and Wu et al. 2021) were replicated using ChatGPTv3.5 and Bard. Outputs (author, title, publication year, and journal) were compared to the original references and cross‐referenced with medical databases for authenticity and recall. Results: Several themes emerged when comparing Bard and ChatGPT across the three reviews. Bard generated more outputs and had greater recall in Wong et al.'s review, with a broader date range in Jabbour et al.'s review. In Wu et al.'s review, ChatGPT‐2 had higher recall and identified more authentic outputs than Bard‐2. Conclusion: Large language models (LLMs) failed to fully replicate peer‐reviewed methodologies, producing outputs with inaccuracies but identifying relevant, especially recent, articles missed by the references. While human‐led PRISMA‐based reviews remain the gold standard, refining LLMs for literature reviews shows potential.


  • Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis

    by Dylan A. Levy, Ajibola B. Bakare, Robert E. Gurevich, Edward D. McCoul

    Background: Allergic rhinitis (AR) affects millions of people worldwide, impacting quality of life and causing economic burden. Intranasal corticosteroids (INCs) are the mainstay treatment for AR, delivered via aerosol or aqueous sprays. Objective: This systematic review and meta-analysis investigate the comparative efficacy and safety of aerosol and aqueous delivery methods in AR treatment. Methods: Two independent reviewers searched 4 databases (Embrace, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and Web of Science) for English-language, prospective randomized controlled trial (RCT), comparing aqueous and aerosol INCs for AR treatment. Studies were excluded for specific reasons (wrong comparisons, full text unavailable, insufficient data for extraction, wrong patient population, incorrect route of administration (non-intranasal), unverifiable inclusion criteria). Primary outcomes were Total Nasal Symptom Score (TNSS) and subset scores; secondary outcome was adverse event (AEs). Results: No significant difference in overall TNSS was found between the delivery methods. However, aqueous sprays showed a slight edge in reducing specific symptoms like congestion, itching, sneezing, and rhinorrhea. AEs did not differ significantly. Conclusion: Our findings suggest no significant difference in efficacy or safety between aerosol and aqueous INCs for AR treatment. Patient preference should be a primary consideration when choosing a delivery method to optimize adherence and symptom control.


  • Open Access

    Demographic and modifiable risk factors impacting obstructive sleep apnea comorbidities: a New Orleans case–control study

    by Ajibola B. Bakare, Diandra Smith, Zaynab Sidi Mohamed, Tijani Mohammed, Mina Liao, Brian Le, Rizwan Aslam

    Purpose: Obstructive sleep apnea (OSA) is a prevalent sleep disorder characterized by recurrent upper airway collapse during sleep, leading to intermittent cessation or reduction of breathing. Associated symptoms include snoring and excessive daytime sleepiness. OSA is linked to a range of comorbidities, primarily cardiovascular and metabolic conditions. However, emerging evidence suggests a broader spectrum of associated health issues. This study aimed to investigate the relationship between OSA comorbidities and demographics as well as modifiable risk factors within a New Orleans patient population. Methods: A case–control study encompassing 19,875 patients (313 with OSA, 19,558 without) was conducted. Nominal logistic regression analyzed differences between OSA and non-OSA groups, while prevalence of comorbidities was compared across demographic and modifiable risk factors within each group. Results: Our findings revealed increased odds of cardiovascular and respiratory disorders among OSA patients compared to controls. OSA risk was elevated in males, middle-aged individuals, individuals with body mass index (BMI) greater than 30, and former smokers. Cardiovascular and metabolic conditions were the most prevalent comorbidities in the OSA group, with additional comorbidities including gastrointestinal, respiratory, psychiatric, and renal disorders. Conclusion: These results highlight the multifaceted health burden associated with OSA. Comprehensive management strategies addressing both well-established and emerging comorbidities are essential for optimizing patient outcomes.


  • Nasal Corticosteroid Delivery Methods in Chronic Rhinosinusitis With Polyps: A Systematic Review

    by Robert E. Gurevich, Ajibola B. Bakare, Dylan A. Levy, Edward D. McCoul

    Objective: This systematic review evaluates and compares the efficacy and safety of different intranasal corticosteroid delivery methods for treating chronic rhinosinusitis with nasal polyps (CRSwNP).Data Sources: Embase, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and Web of Science were systematically searched from January 1, 1980 to January 9, 2024.Review Methods: Two independent reviewers searched 4 databases for English‐language, prospective randomized controlled trials (RCT), comparing different delivery methods of corticosteroids for the treatment of CRSwNP. Studies were excluded for specific reasons (wrong comparisons, wrong intervention, wrong patient population, and wrong route of administration).Results: The data search identified 2282 studies. After removing duplicates, 1503 studies were screened by title and abstract, with 1479 excluded for not meeting criteria. Eighteen full‐text articles were assessed for eligibility, and 5 RCTs were included in the review. Both short‐ and long‐term treatments with nebulizer, aerosol spray, and nasal drop methods demonstrated similar efficacy to oral corticosteroids (OCS) but with a better safety profile. Long‐term use of aqueous sprays showed clinical improvement but was less effective than other non‐aqueous delivery methods.Conclusion: Non‐aqueous delivery methods, including nebulizers, aerosol sprays, and nasal drops offer a safe alternative to OCS without systemic side effects. Patients using aqueous formulations should be advised on the importance of long‐term adherence to achieve symptom improvement.


  • Open Access

    Sleep apnea and ischemic stroke— a perspective for translational preclinical modelling

    by I.J. Biose, A.B. Bakare, H. Wang, T.E. Gressett, G.J. Bix


  • Open Access

    Evaluating the Bioenergetics Health Index Ratio in Leigh Syndrome Fibroblasts to Understand Disease Severity

    by Ajibola B. Bakare, Joseph Dean, Qun Chen, Vedant Thorat, Yimin Huang, Thomas LaFramboise, Edward J. Lesnefsky, Shilpa Iyer

    Several pediatric mitochondrial disorders, including Leigh syndrome (LS), impact mitochondrial (mt) genetics, development, and metabolism, leading to complex pathologies and energy failure. The extent to which pathogenic mtDNA variants regulate disease severity in LS is currently not well understood. To better understand this relationship, we computed a glycolytic bioenergetics health index (BHI) for measuring mitochondrial dysfunction in LS patient fibroblast cells harboring varying percentages of pathogenic mutant mtDNA (T8993G, T9185C) exhibiting deficiency in complex V or complex I (T10158C, T12706C). A high percentage (>90%) of pathogenic mtDNA in cells affecting complex V and a low percentage (<39%) of pathogenic mtDNA in cells affecting complex I was quantified. Levels of defective enzyme activities of the electron transport chain correlated with the percentage of pathogenic mtDNA. Subsequent bioenergetics assays showed cell lines relied on both OXPHOS and glycolysis for meeting energy requirements. Results suggest that whereas the precise mechanism of LS has not been elucidated, a multi-pronged approach taking into consideration the specific pathogenic mtDNA variant, glycolytic BHI, and the composite BHI (average ratio of oxphos to glycolysis) can aid in better understanding the factors influencing disease severity in LS.


  • Open Access

    Cell-Permeable Succinate Increases Mitochondrial Membrane Potential and Glycolysis in Leigh Syndrome Patient Fibroblasts

    by Ajibola B. Bakare, Raj R. Rao, Shilpa Iyer

    Mitochondrial disorders represent a large group of severe genetic disorders mainly impacting organ systems with high energy requirements. Leigh syndrome (LS) is a classic example of a mitochondrial disorder resulting from pathogenic mutations that disrupt oxidative phosphorylation capacities. Currently, evidence-based therapy directed towards treating LS is sparse. Recently, the cell-permeant substrates responsible for regulating the electron transport chain have gained attention as therapeutic agents for mitochondrial diseases. We explored the therapeutic effects of introducing tricarboxylic acid cycle (TCA) intermediate substrate, succinate, as a cell-permeable prodrug NV118, to alleviate some of the mitochondrial dysfunction in LS. The results suggest that a 24-hour treatment with prodrug NV118 elicited an upregulation of glycolysis and mitochondrial membrane potential while inhibiting intracellular reactive oxygen species in LS cells. The results from this study suggest an important role for TCA intermediates for treating mitochondrial dysfunction in LS. We show, here, that NV118 could serve as a therapeutic agent for LS resulting from mutations in mtDNA in complex I and complex V dysfunctions.


  • Open Access

    Quantifying Mitochondrial Dynamics in Patient Fibroblasts with Multiple Developmental Defects and Mitochondrial Disorders

    by Ajibola B. Bakare, Julienne Daniel, Joshua Stabach, Anapaula Rojas, Austin Bell, Brooke Henry, Shilpa Iyer

    Mitochondria are dynamic organelles that undergo rounds of fission and fusion and exhibit a wide range of morphologies that contribute to the regulation of different signaling pathways and various cellular functions. It is important to understand the differences between mitochondrial structure in health and disease so that therapies can be developed to maintain the homeostatic balance of mitochondrial dynamics. Mitochondrial disorders are multisystemic and characterized by complex and variable clinical pathologies. The dynamics of mitochondria in mitochondrial disorders is thus worthy of investigation. Therefore, in this study, we performed a comprehensive analysis of mitochondrial dynamics in ten patient-derived fibroblasts containing different mutations and deletions associated with various mitochondrial disorders. Our results suggest that the most predominant morphological signature for mitochondria in the diseased state is fragmentation, with eight out of the ten cell lines exhibiting characteristics consistent with fragmented mitochondria. To our knowledge, this is the first comprehensive study that quantifies mitochondrial dynamics in cell lines with a wide array of developmental and mitochondrial disorders. A more thorough analysis of the correlations between mitochondrial dynamics, mitochondrial genome perturbations, and bioenergetic dysfunction will aid in identifying unique morphological signatures of various mitochondrial disorders in the future.


  • Lifetime reproductive effort is equal between the sexes in seed beetles (Callosobruchus maculatus): dispelling the myth of the cheap male

    by James D. Wagner, Ajibola Bakare

    In the evolution of sexual reproduction, the development of asymmetrical gametes (anisogamy) often leads to the characterisation that males invest less in reproduction than females. This view is founded on the fact that male investment in individual gametes (sperm) and in gonadal tissue is often less than that of females. While it may be true that within a single mating interaction the relative reproductive investment by males and females differs, over their respective lifetimes an evolutionary view predicts that total lifetime reproductive investment should be the same for both sexes. We tested this prediction by measuring total reproductive investment in reproducing adult male and female seed beetles. Since seed beetle adults are facultatively aphagous, not needing to feed or drink as adults, we could track the daily loss of biomass in the reproducing adults as a proxy for total lifetime investment in maintenance and reproduction. By the end of their lifetime there was not a significant difference in total reproductive effort between males and females. Both sexes invested 70 ± 1% SE of their initial body mass in maintenance and reproduction. Altering sex ratios, creating male-biased or female-biased treatments, significantly influenced total investment between the sexes, but not in the manner predicted. Ours is one of the few studies that have measured total adult lifetime reproductive investment in an organism, and our results support the theoretical expectation of equal total reproductive investment between the sexes.